nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—nerve—hypothyroidism	0.0208	0.113	CbGeAlD
Tapentadol—OPRM1—nerve—hypothyroidism	0.0191	0.104	CbGeAlD
Tapentadol—CYP2C19—urine—hypothyroidism	0.019	0.103	CbGeAlD
Tapentadol—Feeling hot—Liotrix—hypothyroidism	0.0184	0.0267	CcSEcCtD
Tapentadol—Disorientation—Levothyroxine—hypothyroidism	0.0159	0.0231	CcSEcCtD
Tapentadol—Disorientation—Dextrothyroxine—hypothyroidism	0.0159	0.0231	CcSEcCtD
Tapentadol—CYP2C9—urine—hypothyroidism	0.0148	0.0802	CbGeAlD
Tapentadol—SLC6A2—nerve—hypothyroidism	0.014	0.0759	CbGeAlD
Tapentadol—Tachycardia—Liothyronine—hypothyroidism	0.0139	0.0202	CcSEcCtD
Tapentadol—Irritability—Dextrothyroxine—hypothyroidism	0.0136	0.0197	CcSEcCtD
Tapentadol—Irritability—Levothyroxine—hypothyroidism	0.0136	0.0197	CcSEcCtD
Tapentadol—Hypotension—Liothyronine—hypothyroidism	0.0133	0.0193	CcSEcCtD
Tapentadol—Disorientation—Liotrix—hypothyroidism	0.0117	0.017	CcSEcCtD
Tapentadol—Weight decreased—Dextrothyroxine—hypothyroidism	0.0111	0.0162	CcSEcCtD
Tapentadol—Weight decreased—Levothyroxine—hypothyroidism	0.0111	0.0162	CcSEcCtD
Tapentadol—CYP2D6—urine—hypothyroidism	0.0111	0.0602	CbGeAlD
Tapentadol—Irritability—Liotrix—hypothyroidism	0.01	0.0145	CcSEcCtD
Tapentadol—SLC6A4—Monoamine Transport—SLC5A7—hypothyroidism	0.00864	0.0678	CbGpPWpGaD
Tapentadol—Tension—Levothyroxine—hypothyroidism	0.00842	0.0122	CcSEcCtD
Tapentadol—Tension—Dextrothyroxine—hypothyroidism	0.00842	0.0122	CcSEcCtD
Tapentadol—Nervousness—Levothyroxine—hypothyroidism	0.00833	0.0121	CcSEcCtD
Tapentadol—Nervousness—Dextrothyroxine—hypothyroidism	0.00833	0.0121	CcSEcCtD
Tapentadol—Weight decreased—Liotrix—hypothyroidism	0.00819	0.0119	CcSEcCtD
Tapentadol—Tremor—Levothyroxine—hypothyroidism	0.00804	0.0117	CcSEcCtD
Tapentadol—Tremor—Dextrothyroxine—hypothyroidism	0.00804	0.0117	CcSEcCtD
Tapentadol—Agitation—Levothyroxine—hypothyroidism	0.00788	0.0114	CcSEcCtD
Tapentadol—Agitation—Dextrothyroxine—hypothyroidism	0.00788	0.0114	CcSEcCtD
Tapentadol—Angioedema—Levothyroxine—hypothyroidism	0.00784	0.0114	CcSEcCtD
Tapentadol—Angioedema—Dextrothyroxine—hypothyroidism	0.00784	0.0114	CcSEcCtD
Tapentadol—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00782	0.0614	CbGpPWpGaD
Tapentadol—UGT1A9—liver—hypothyroidism	0.00766	0.0416	CbGeAlD
Tapentadol—Palpitations—Dextrothyroxine—hypothyroidism	0.00758	0.011	CcSEcCtD
Tapentadol—Palpitations—Levothyroxine—hypothyroidism	0.00758	0.011	CcSEcCtD
Tapentadol—Convulsion—Levothyroxine—hypothyroidism	0.00743	0.0108	CcSEcCtD
Tapentadol—Convulsion—Dextrothyroxine—hypothyroidism	0.00743	0.0108	CcSEcCtD
Tapentadol—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00743	0.0583	CbGpPWpGaD
Tapentadol—Arthralgia—Dextrothyroxine—hypothyroidism	0.0073	0.0106	CcSEcCtD
Tapentadol—Arthralgia—Levothyroxine—hypothyroidism	0.0073	0.0106	CcSEcCtD
Tapentadol—Anxiety—Dextrothyroxine—hypothyroidism	0.00728	0.0106	CcSEcCtD
Tapentadol—Anxiety—Levothyroxine—hypothyroidism	0.00728	0.0106	CcSEcCtD
Tapentadol—Hypoaesthesia—Liotrix—hypothyroidism	0.00721	0.0105	CcSEcCtD
Tapentadol—Confusional state—Dextrothyroxine—hypothyroidism	0.00706	0.0102	CcSEcCtD
Tapentadol—Confusional state—Levothyroxine—hypothyroidism	0.00706	0.0102	CcSEcCtD
Tapentadol—Shock—Levothyroxine—hypothyroidism	0.00689	0.01	CcSEcCtD
Tapentadol—Shock—Dextrothyroxine—hypothyroidism	0.00689	0.01	CcSEcCtD
Tapentadol—Tachycardia—Levothyroxine—hypothyroidism	0.00683	0.00992	CcSEcCtD
Tapentadol—Tachycardia—Dextrothyroxine—hypothyroidism	0.00683	0.00992	CcSEcCtD
Tapentadol—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00677	0.00983	CcSEcCtD
Tapentadol—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00677	0.00983	CcSEcCtD
Tapentadol—UGT2B7—testis—hypothyroidism	0.00653	0.0355	CbGeAlD
Tapentadol—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00638	0.00926	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00638	0.00926	CcSEcCtD
Tapentadol—Insomnia—Dextrothyroxine—hypothyroidism	0.00633	0.00919	CcSEcCtD
Tapentadol—Insomnia—Levothyroxine—hypothyroidism	0.00633	0.00919	CcSEcCtD
Tapentadol—Dyspnoea—Levothyroxine—hypothyroidism	0.00624	0.00906	CcSEcCtD
Tapentadol—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00624	0.00906	CcSEcCtD
Tapentadol—Tension—Liotrix—hypothyroidism	0.00619	0.00899	CcSEcCtD
Tapentadol—UGT2B7—liver—hypothyroidism	0.00617	0.0336	CbGeAlD
Tapentadol—Nervousness—Liotrix—hypothyroidism	0.00613	0.0089	CcSEcCtD
Tapentadol—Fatigue—Levothyroxine—hypothyroidism	0.00604	0.00876	CcSEcCtD
Tapentadol—Fatigue—Dextrothyroxine—hypothyroidism	0.00604	0.00876	CcSEcCtD
Tapentadol—Vision blurred—Liotrix—hypothyroidism	0.00595	0.00863	CcSEcCtD
Tapentadol—Tremor—Liotrix—hypothyroidism	0.00591	0.00858	CcSEcCtD
Tapentadol—Agitation—Liotrix—hypothyroidism	0.0058	0.00842	CcSEcCtD
Tapentadol—Feeling abnormal—Levothyroxine—hypothyroidism	0.00577	0.00838	CcSEcCtD
Tapentadol—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00577	0.00838	CcSEcCtD
Tapentadol—Angioedema—Liotrix—hypothyroidism	0.00577	0.00837	CcSEcCtD
Tapentadol—HTR3A—blood—hypothyroidism	0.00576	0.0313	CbGeAlD
Tapentadol—OPRK1—cerebellum—hypothyroidism	0.00567	0.0308	CbGeAlD
Tapentadol—Syncope—Liotrix—hypothyroidism	0.00566	0.00822	CcSEcCtD
Tapentadol—Palpitations—Liotrix—hypothyroidism	0.00558	0.0081	CcSEcCtD
Tapentadol—Urticaria—Levothyroxine—hypothyroidism	0.00556	0.00808	CcSEcCtD
Tapentadol—Urticaria—Dextrothyroxine—hypothyroidism	0.00556	0.00808	CcSEcCtD
Tapentadol—Loss of consciousness—Liotrix—hypothyroidism	0.00555	0.00805	CcSEcCtD
Tapentadol—Convulsion—Liotrix—hypothyroidism	0.00547	0.00794	CcSEcCtD
Tapentadol—Arthralgia—Liotrix—hypothyroidism	0.00537	0.0078	CcSEcCtD
Tapentadol—Anxiety—Liotrix—hypothyroidism	0.00535	0.00777	CcSEcCtD
Tapentadol—OPRM1—blood—hypothyroidism	0.00528	0.0287	CbGeAlD
Tapentadol—Confusional state—Liotrix—hypothyroidism	0.00519	0.00754	CcSEcCtD
Tapentadol—Oedema—Liotrix—hypothyroidism	0.00515	0.00748	CcSEcCtD
Tapentadol—Anaphylactic shock—Liotrix—hypothyroidism	0.00515	0.00748	CcSEcCtD
Tapentadol—Infection—Liotrix—hypothyroidism	0.00512	0.00743	CcSEcCtD
Tapentadol—Shock—Liotrix—hypothyroidism	0.00507	0.00736	CcSEcCtD
Tapentadol—Tachycardia—Liotrix—hypothyroidism	0.00503	0.0073	CcSEcCtD
Tapentadol—Asthenia—Dextrothyroxine—hypothyroidism	0.00502	0.00729	CcSEcCtD
Tapentadol—Asthenia—Levothyroxine—hypothyroidism	0.00502	0.00729	CcSEcCtD
Tapentadol—Hyperhidrosis—Liotrix—hypothyroidism	0.00498	0.00723	CcSEcCtD
Tapentadol—Pruritus—Levothyroxine—hypothyroidism	0.00495	0.00719	CcSEcCtD
Tapentadol—Pruritus—Dextrothyroxine—hypothyroidism	0.00495	0.00719	CcSEcCtD
Tapentadol—Hypotension—Liotrix—hypothyroidism	0.00481	0.00699	CcSEcCtD
Tapentadol—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00479	0.00695	CcSEcCtD
Tapentadol—Diarrhoea—Levothyroxine—hypothyroidism	0.00479	0.00695	CcSEcCtD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00478	0.0375	CbGpPWpGaD
Tapentadol—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00469	0.00681	CcSEcCtD
Tapentadol—Insomnia—Liotrix—hypothyroidism	0.00466	0.00676	CcSEcCtD
Tapentadol—Paraesthesia—Liotrix—hypothyroidism	0.00462	0.00671	CcSEcCtD
Tapentadol—Dyspnoea—Liotrix—hypothyroidism	0.00459	0.00667	CcSEcCtD
Tapentadol—Decreased appetite—Liotrix—hypothyroidism	0.00448	0.0065	CcSEcCtD
Tapentadol—Vomiting—Levothyroxine—hypothyroidism	0.00445	0.00646	CcSEcCtD
Tapentadol—Vomiting—Dextrothyroxine—hypothyroidism	0.00445	0.00646	CcSEcCtD
Tapentadol—Fatigue—Liotrix—hypothyroidism	0.00444	0.00645	CcSEcCtD
Tapentadol—SLC6A2—gonad—hypothyroidism	0.00444	0.0241	CbGeAlD
Tapentadol—Rash—Dextrothyroxine—hypothyroidism	0.00441	0.00641	CcSEcCtD
Tapentadol—Rash—Levothyroxine—hypothyroidism	0.00441	0.00641	CcSEcCtD
Tapentadol—Dermatitis—Levothyroxine—hypothyroidism	0.00441	0.0064	CcSEcCtD
Tapentadol—Dermatitis—Dextrothyroxine—hypothyroidism	0.00441	0.0064	CcSEcCtD
Tapentadol—Constipation—Liotrix—hypothyroidism	0.0044	0.00639	CcSEcCtD
Tapentadol—SLC6A4—blood—hypothyroidism	0.00439	0.0239	CbGeAlD
Tapentadol—Headache—Dextrothyroxine—hypothyroidism	0.00439	0.00637	CcSEcCtD
Tapentadol—Headache—Levothyroxine—hypothyroidism	0.00439	0.00637	CcSEcCtD
Tapentadol—OPRM1—testis—hypothyroidism	0.00437	0.0237	CbGeAlD
Tapentadol—Feeling abnormal—Liotrix—hypothyroidism	0.00424	0.00616	CcSEcCtD
Tapentadol—Nausea—Dextrothyroxine—hypothyroidism	0.00416	0.00604	CcSEcCtD
Tapentadol—Nausea—Levothyroxine—hypothyroidism	0.00416	0.00604	CcSEcCtD
Tapentadol—SLC6A4—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00413	0.0324	CbGpPWpGaD
Tapentadol—Urticaria—Liotrix—hypothyroidism	0.00409	0.00594	CcSEcCtD
Tapentadol—SLC6A2—adrenal gland—hypothyroidism	0.00387	0.021	CbGeAlD
Tapentadol—Hypersensitivity—Liotrix—hypothyroidism	0.00379	0.00551	CcSEcCtD
Tapentadol—CYP2C9—heart—hypothyroidism	0.00378	0.0206	CbGeAlD
Tapentadol—Asthenia—Liotrix—hypothyroidism	0.00369	0.00536	CcSEcCtD
Tapentadol—Pruritus—Liotrix—hypothyroidism	0.00364	0.00529	CcSEcCtD
Tapentadol—CYP2C19—blood—hypothyroidism	0.00364	0.0198	CbGeAlD
Tapentadol—CYP2C9—cardiovascular system—hypothyroidism	0.00357	0.0194	CbGeAlD
Tapentadol—Diarrhoea—Liotrix—hypothyroidism	0.00352	0.00512	CcSEcCtD
Tapentadol—Dizziness—Liotrix—hypothyroidism	0.00341	0.00494	CcSEcCtD
Tapentadol—Vomiting—Liotrix—hypothyroidism	0.00327	0.00475	CcSEcCtD
Tapentadol—Rash—Liotrix—hypothyroidism	0.00325	0.00471	CcSEcCtD
Tapentadol—Dermatitis—Liotrix—hypothyroidism	0.00324	0.00471	CcSEcCtD
Tapentadol—Headache—Liotrix—hypothyroidism	0.00323	0.00468	CcSEcCtD
Tapentadol—SLC6A2—testis—hypothyroidism	0.0032	0.0174	CbGeAlD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00308	0.0242	CbGpPWpGaD
Tapentadol—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00306	0.024	CbGpPWpGaD
Tapentadol—Nausea—Liotrix—hypothyroidism	0.00306	0.00444	CcSEcCtD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00299	0.0234	CbGpPWpGaD
Tapentadol—CYP2C19—liver—hypothyroidism	0.00284	0.0155	CbGeAlD
Tapentadol—CYP2C9—blood—hypothyroidism	0.00282	0.0153	CbGeAlD
Tapentadol—UGT2B7—NRF2 pathway—SLC5A7—hypothyroidism	0.00261	0.0205	CbGpPWpGaD
Tapentadol—OPRD1—Peptide GPCRs—TSHR—hypothyroidism	0.00257	0.0202	CbGpPWpGaD
Tapentadol—SLC6A4—NRF2 pathway—SLC5A7—hypothyroidism	0.00257	0.0201	CbGpPWpGaD
Tapentadol—OPRK1—Peptide GPCRs—TSHR—hypothyroidism	0.00225	0.0177	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00221	0.0173	CbGpPWpGaD
Tapentadol—CYP2C9—liver—hypothyroidism	0.00221	0.012	CbGeAlD
Tapentadol—UGT1A9—NRF2 pathway—SLC5A7—hypothyroidism	0.00212	0.0166	CbGpPWpGaD
Tapentadol—CYP2D6—blood—hypothyroidism	0.00212	0.0115	CbGeAlD
Tapentadol—CYP2D6—female gonad—hypothyroidism	0.00197	0.0107	CbGeAlD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00192	0.0151	CbGpPWpGaD
Tapentadol—OPRM1—Peptide GPCRs—TSHR—hypothyroidism	0.0019	0.0149	CbGpPWpGaD
Tapentadol—CYP2D6—testis—hypothyroidism	0.00175	0.00952	CbGeAlD
Tapentadol—OPRM1—G-protein activation—POMC—hypothyroidism	0.00167	0.0131	CbGpPWpGaD
Tapentadol—CYP2D6—liver—hypothyroidism	0.00165	0.009	CbGeAlD
Tapentadol—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00165	0.0129	CbGpPWpGaD
Tapentadol—CYP2D6—cerebellum—hypothyroidism	0.00162	0.00879	CbGeAlD
Tapentadol—OPRM1—TCR Signaling Pathway—SH2B3—hypothyroidism	0.00145	0.0114	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00139	0.0109	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00136	0.0106	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00132	0.0103	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00123	0.00963	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00119	0.00933	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00115	0.00904	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00109	0.00856	CbGpPWpGaD
Tapentadol—UGT2B7—NRF2 pathway—SLC5A5—hypothyroidism	0.00104	0.00818	CbGpPWpGaD
Tapentadol—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.00103	0.00805	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.001	0.00789	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—VAV3—hypothyroidism	0.000996	0.00782	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00091	0.00714	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000882	0.00692	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—SLC5A5—hypothyroidism	0.000847	0.00664	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000811	0.00636	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000811	0.00636	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000798	0.00626	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000766	0.00601	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000712	0.00559	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000711	0.00558	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000711	0.00558	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000707	0.00555	CbGpPWpGaD
Tapentadol—OPRM1—Opioid Signalling—POMC—hypothyroidism	0.000694	0.00545	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—TRH—hypothyroidism	0.000693	0.00544	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000674	0.00529	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000625	0.00491	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000625	0.0049	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—TSHB—hypothyroidism	0.000617	0.00485	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—TSHR—hypothyroidism	0.000617	0.00485	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—TRH—hypothyroidism	0.000607	0.00477	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000601	0.00472	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000601	0.00472	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000586	0.0046	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—IYD—hypothyroidism	0.000564	0.00443	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000556	0.00436	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—TSHB—hypothyroidism	0.000541	0.00425	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—TSHR—hypothyroidism	0.000541	0.00425	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000528	0.00414	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000526	0.00413	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—TRH—hypothyroidism	0.000513	0.00403	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ATP5O—hypothyroidism	0.00048	0.00376	CbGpPWpGaD
Tapentadol—UGT2B7—Biological oxidations—POMC—hypothyroidism	0.000478	0.00375	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000478	0.00375	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000473	0.00372	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—IYD—hypothyroidism	0.000458	0.0036	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000458	0.00359	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000458	0.00359	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TPO—hypothyroidism	0.000451	0.00354	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000438	0.00343	CbGpPWpGaD
Tapentadol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000424	0.00333	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000419	0.00329	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000415	0.00326	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000414	0.00325	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—POMC—hypothyroidism	0.000399	0.00313	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TRH—hypothyroidism	0.000391	0.00307	CbGpPWpGaD
Tapentadol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00039	0.00306	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ATP5O—hypothyroidism	0.00039	0.00306	CbGpPWpGaD
Tapentadol—UGT1A9—Biological oxidations—POMC—hypothyroidism	0.000389	0.00305	CbGpPWpGaD
Tapentadol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000387	0.00303	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TPO—hypothyroidism	0.000366	0.00288	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—AVP—hypothyroidism	0.000364	0.00286	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TRH—hypothyroidism	0.000355	0.00279	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000354	0.00278	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000351	0.00275	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—POMC—hypothyroidism	0.00035	0.00275	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TSHB—hypothyroidism	0.000349	0.00274	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TSHR—hypothyroidism	0.000349	0.00274	CbGpPWpGaD
Tapentadol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000344	0.0027	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TRH—hypothyroidism	0.000343	0.00269	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00034	0.00266	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—AVP—hypothyroidism	0.000319	0.0025	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000318	0.00249	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TSHB—hypothyroidism	0.000317	0.00249	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TSHR—hypothyroidism	0.000317	0.00249	CbGpPWpGaD
Tapentadol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000316	0.00248	CbGpPWpGaD
Tapentadol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000313	0.00246	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TRH—hypothyroidism	0.000312	0.00245	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TSHB—hypothyroidism	0.000306	0.0024	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TSHR—hypothyroidism	0.000306	0.0024	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—POMC—hypothyroidism	0.000296	0.00232	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TRH—hypothyroidism	0.00029	0.00228	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000282	0.00222	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000278	0.00219	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TSHB—hypothyroidism	0.000278	0.00218	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TSHR—hypothyroidism	0.000278	0.00218	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—AVP—hypothyroidism	0.00027	0.00212	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TRH—hypothyroidism	0.000263	0.00207	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000259	0.00203	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000259	0.00203	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CLTC—hypothyroidism	0.000243	0.00191	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—POMC—hypothyroidism	0.000242	0.0019	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000235	0.00185	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000235	0.00184	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000235	0.00184	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000222	0.00175	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—IYD—hypothyroidism	0.000215	0.00169	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—VAV3—hypothyroidism	0.000213	0.00168	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CLTC—hypothyroidism	0.000213	0.00167	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—POMC—hypothyroidism	0.000212	0.00166	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TRH—hypothyroidism	0.00021	0.00165	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TSHB—hypothyroidism	0.000209	0.00164	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AVP—hypothyroidism	0.000206	0.00161	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—IYD—hypothyroidism	0.000198	0.00156	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—IYD—hypothyroidism	0.000196	0.00154	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—VAV3—hypothyroidism	0.000194	0.00152	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TSHR—hypothyroidism	0.000187	0.00147	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TSHB—hypothyroidism	0.000187	0.00147	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—VAV3—hypothyroidism	0.000187	0.00147	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AVP—hypothyroidism	0.000187	0.00147	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3C2A—hypothyroidism	0.000186	0.00146	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TRH—hypothyroidism	0.000184	0.00145	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000183	0.00144	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000183	0.00143	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AVP—hypothyroidism	0.00018	0.00142	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CLTC—hypothyroidism	0.00018	0.00141	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—POMC—hypothyroidism	0.000179	0.00141	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TPO—hypothyroidism	0.000172	0.00135	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—VAV3—hypothyroidism	0.00017	0.00133	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TSHB—hypothyroidism	0.00017	0.00133	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000168	0.00132	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000168	0.00132	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000167	0.00131	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SH2B3—hypothyroidism	0.000167	0.00131	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000166	0.00131	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TSHB—hypothyroidism	0.000164	0.00129	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TSHR—hypothyroidism	0.000164	0.00129	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AVP—hypothyroidism	0.000164	0.00129	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00016	0.00125	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TPO—hypothyroidism	0.000158	0.00124	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—VAV3—hypothyroidism	0.000158	0.00124	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TPO—hypothyroidism	0.000157	0.00123	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—SLC5A5—hypothyroidism	0.000156	0.00123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TRH—hypothyroidism	0.000156	0.00122	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AVP—hypothyroidism	0.000152	0.0012	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3C2A—hypothyroidism	0.000151	0.00119	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000149	0.00117	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SH2B3—hypothyroidism	0.000146	0.00115	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000145	0.00114	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—VAV3—hypothyroidism	0.000144	0.00113	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TSHB—hypothyroidism	0.000139	0.00109	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TSHR—hypothyroidism	0.000139	0.00109	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AVP—hypothyroidism	0.000138	0.00109	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—POMC—hypothyroidism	0.000137	0.00107	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SLC5A5—hypothyroidism	0.000127	0.000997	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—POMC—hypothyroidism	0.000124	0.000974	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRL—hypothyroidism	0.000124	0.000971	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SH2B3—hypothyroidism	0.000124	0.00097	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—POMC—hypothyroidism	0.00012	0.00094	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VAV3—hypothyroidism	0.000114	0.000899	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AVP—hypothyroidism	0.00011	0.000866	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—hypothyroidism	0.000109	0.000854	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRL—hypothyroidism	0.000109	0.000852	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—hypothyroidism	0.000101	0.000795	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VAV3—hypothyroidism	0.0001	0.000788	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AVP—hypothyroidism	9.67e-05	0.000759	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—hypothyroidism	9.2e-05	0.000722	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRL—hypothyroidism	9.17e-05	0.00072	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VAV3—hypothyroidism	8.48e-05	0.000666	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—hypothyroidism	8.18e-05	0.000642	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AVP—hypothyroidism	8.17e-05	0.000642	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TSHB—hypothyroidism	7.97e-05	0.000626	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TSHB—hypothyroidism	7.33e-05	0.000576	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—hypothyroidism	7.33e-05	0.000575	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TSHB—hypothyroidism	7.27e-05	0.000571	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	7.11e-05	0.000558	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF1—hypothyroidism	7.05e-05	0.000553	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.01e-05	0.00055	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—hypothyroidism	6.64e-05	0.000521	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	6.54e-05	0.000513	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	6.48e-05	0.000509	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—hypothyroidism	6.43e-05	0.000504	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.39e-05	0.000502	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1—hypothyroidism	6.18e-05	0.000485	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC5A5—hypothyroidism	5.97e-05	0.000468	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC5A5—hypothyroidism	5.49e-05	0.000431	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC5A5—hypothyroidism	5.44e-05	0.000427	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—hypothyroidism	5.43e-05	0.000426	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1—hypothyroidism	5.23e-05	0.00041	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—hypothyroidism	3.12e-05	0.000245	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—hypothyroidism	2.87e-05	0.000225	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—hypothyroidism	2.85e-05	0.000223	CbGpPWpGaD
